Emcure Pharmaceuticals Limited — Board Meeting, 06-02-2025: Outcome of Board Meeting

Emcure Pharmaceuticals has announced a board meeting to discuss its financial results for the quarter and nine months ended December 31, 2024. Key agenda items include the review of consolidated financial performance and a detailed discussion on business strategies moving forward. Recent performance highlights show a 17.7% year-on-year growth in revenue from operations, amounting to ₹1,963 Cr, with a substantial profit after tax increase of 30.3%, reaching ₹156 Cr. The international market, particularly Canada, has shown robust growth, contributing significantly to overall revenue.